CompletedNCT04390165

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital Sultanah Bahiyah
Principal Investigator
Siti Sabzah Mohd Hashim, MD MS
Hospital Sultanah Bahiyah
Intervention
Patient-Reported Online Questionnaire on Olfactory & Taste Disturbances(other)
Enrollment
498 target
Eligibility
18 years · All sexes
Timeline
2020 – 2020

Study locations (14)

Collaborators

Hospital Tuanku Fauziah, Kangar, Perlis · Penang Hospital, Malaysia · Hospital Raja Permaisuri Bainun · Hospital Sungai Buloh, Selangor · Kuala Lumpur General Hospital · Hospital Tuanku Jaafar, Seremban, Negeri Sembilan · Hospital Melaka, Melaka · Hospital Enche Besar Hajjah Khalsom, Kluang, Johor · Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan · Hospital Sultanah Nur Zahirah, Kuala Terengganu · Hospital Tengku Ampuan Afzan, Kuantan, Pahang · Sarawak General Hospital · Hospital Queen Elizabeth, Malaysia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04390165 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome →

← Back to all trials